Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes

Human Immunology

Volumn 71, Issue 8, 2010, Pages 799-803

  Jobim, Mariana ^a,b   Chagastelles, Pedro ^b   Salim, Patrícia H ^b   Portela, Pamela ^a   Wilson, Timothy J ^b   Curti, Alessandra G ^a   Jobim, Maria Regina ^a   João, Daniele A ^a   Nardi, Nance Beyer ^b   Tschiedel, Balduino ^c   Jobim, Luiz Fernando ^a,b   Roesler, Rafael ^a,b,d   Schwartsmann, Gilberto ^a,b,d  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Hospital Conceicao   (Brazil)

^d National Institute for Translational Medicine INCT TM   (Brazil)

Author keywords

Human leukocyte antigen; Killer cell immunoglobulin like receptor; Natural killer cell; Type 1 diabetes

Indexed keywords

HLA B ANTIGEN; HLA B BW4 ANTIGEN; HLA C ANTIGEN; HLA C1 ANTIGEN; HLA C2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ARTICLE; BRAZIL; CAUCASIAN; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; BRAZIL; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-C ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL4; RECEPTORS, KIR3DL2;

EID: 77954760110     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.05.014     Document Type: Article

References (48)

1. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
2. Bottazzo G.F., Dean B.M., McNally J.M., MacKay E.H., Swift P.G., Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985, 313:353-360.
3. Baekkeskov S., Nielsen J.H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982, 298:167-169.
4. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983, 222:1337-1339.
5. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347:151-156.
6. Hawkes C.J., Wasmeier C., Christie M.R., Hutton J.C. Identification of the 37 kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 1996, 45:1187-1192.
7. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104:17040-17045.
8. Singal D.P., Blajchman M.A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 1973, 22:429-432.
9. Nerup J., Platz P., Andersen O.O., Christy M., Lyngsoe J., Poulsen J.E., et al. HL-A antigens and diabetes mellitus. Lancet 1974, 2:864-866.
10. Thomson G. HLA disease associations: Models for insulin dependent diabetes mellitus and the study of complex human genetic disorders. Annu Rev Genet 1988, 22:31-50.
11. Boyton R.J., Altmann D.M. Natural killer cells, killer immunoglobulin-like receptor and human antigen class I in disease. Clin Exp Immunol 2007, 149:1-8.
12. Campbell K.S., Dessing M., Lopez-Botet M., Cella M., Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 1996, 93-100.
13. Suto Y., Maenaka K., Yabe T., Hirai M., Tokunaga K., Tadok K., Juji T. Chromosomal localization of the human natural killer cell class I receptor family genes to 19q13.4 by fluorescence in situ hybridization. Genomics 1996, 35:270-272.
14. Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000, 97:4778-4783.
15. Rajalingam R., Hong M., Adams E.J., Shum B.P., Guethlein L.A., Parham P., Short K.I.R. Haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes. J Exp Med 2001, 193:135-146.
16. O'Connor G.M., Guinan K.J., Cunningham R.T., Middleton D., Parham P., Gardiner C.M. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 2007, 178:235-241.
17. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 1997, 27:3095-3099.
18. Askar M., Avery R., Corey R., Lopez R., Thomas D., Pidwell D., et al. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transplant 2009, 15:1557-1563.
19. Jobim M., Jobim L.F., Salim P.H., Cestari T.F., Toresan R., Gil B.C., et al. A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris. Tissue Antigens 2008, 72:392-396.
20. Płoski R., Luszczek W., Kuśnierczyk P., Nockowski P., Cisło M., Krajewski P., Malejczyk J. A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis. Hum Immunol 2006, 67:521-526.
21. Martin M.P., Nelson G., Lee J.H., Pellett F., Gao X., Wade J., et al. Cutting edge: Susceptibility to psoriatic arthritis: Influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002, 169:2818-2822.
22. Williams F., Meenagh A., Sleator C., Cook D., Fernandez-Vina M., Bowcock A.M., Middleton D. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 2005, 66:836-841.
23. Majorczyk E., Pawlik A., Łuszczek W., Nowak I., Wiśniewski A., Jasek M., Kuśnierczyk P. Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Genes Immun 2007, 8:678-683.
24. Santin I., Castellanos-Rubio A., Perez de Nanclares G. Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. Genes Immun 2007, 8:171-176.
25. Jones D.C., Edgar R.S., Ahmad T., Cummings J.R., Jewell D.P., Trowsdale J., Young N.T. Killer Ig-like receptor (KIR) genotype and HLA ligant combination in ulcerative colitis susceptibility. Genes Immun 2006, 7:576-582.
26. Wilson T.J., Jobim M., Jobim L.F., Portela P., Salim P.H., Rosito M.A., et al. Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitis. Hum Immunol 2010, 71(Nos. 3):293-297.
27. Hollenbach J.A., Ladner M.B., Saeteurn K., Taylor K.D., Mei L., Haritunians T., et al. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand. Immunogenetics 2009, 61:663-671.
28. Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, et al. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol ;200:4785-92.
29. Hiby S.E., Regan L., Lo W., Farrell L., Carrington M., Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008, 23:972-976.
30. Franceschi D.S., Mazini P.S., Rudnick C.C., Sell A.M., Tsuneto L.T., de Melo F.C., et al. Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. Tissue Antigens 2008, 72:478-482.
31. van der Slik A.R., Koeleman B.P., Verduijn W., Bruining G.J., Roep B.O., Giphart M.J. KIR in type 1 diabetes: Disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003, 52:2639-2642.
32. Nikitina-Zake l, Rajalingham R., Rumba I., Sanjeevi C.B. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann N Y Acad Sci 2004, 1037:161-169.
33. Middleton D., Halfpenny I., Meenagh A., Williams F., Sivula J., Tuomilehto-Wolf E. Investigation of KIR gene frequencies in type 1 diabetes mellitus. Hum Immunol 2006, 67:986-990.
34. Park Y., Choi H., Park H., Park S., Yoo E.K., Kim D., Sanjeevi C.B. Predominance of the group A killer Ig-like receptor haplotypes in Korean patients with T1D. Ann NY Acad Sci 2006, 1079:240-250.
35. Santin I., Nanclares G.P., Calvo B., Gaafar A., Castaño L., Bilbao J.R. Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: Association study of KIR gene contents with type 1 diabetes mellitus. Hum Immunol 2006, 67:118-124. GEPV-N Group.
36. van der Slik A.R., Alizadeh B.Z., Koeleman B.P., Roep B.O., Giphart M.J. Modelling KIR-HLA genotype disparities in type 1 diabetes. Tissue Antigens 2007, 69:101-105.
37. Mogami S., Hasegawa G., Nakayama I., Asano M., Hosoda H., Kadono M., et al. Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes. Tissue Antigens 2007, 70:506.
38. Shastry A., Sedimbi S.K., Rajalingam R., Nikitina-Zake L., Rumba I., Wigzell H., Sanjeevi C.B. Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. Int J Immunogenet 2008, 35:439-446.
39. Ramos-Lopez E., Scholten F., Aminkeng F., Wild C., Kalhes H., Seidl C., et al. Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding. Tissue Antigens 2009, 73:599-603.
40. 3Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26:5-20. Expert Committee on the Diagnosis and Classification of Diabetes.
41. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
42. Gomez-Lozano N., Vilches C. Genotyping of human killer-immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers an update. Tissue Antigens 2002, 59:84-93.
43. Bunce M., O'Neill C.M., Barnardo M.C., et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primers mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46:355-367.
44. Jobim M., Salim P.H., Portela P., Wilson T.J., Fraportti J., Baronio D., et al. Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of Southern Brazil. Int J Immunogenet 2010.
45. Rudnick C.C., Franceschi D.S., Marangon A.V., Guelsin G.A., Sell A.M., Visentainer J.E. Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná. Hum Immunol 2008, 69:872-876.
46. Middleton D., Meenagh A., Moscoso J., Arnaiz-Villena A. Killer immunoglobulin receptor gene and allele frequencies in Caucasoid, Oriental and Black populations from different continents. Tissue Antigens 2007, 71:105-113.
47. Shi F., Ljunggren H., Sarvetnick N. Innate immunity and autoimmunity: From self-protection to self-destruction. Trends Immunol 2001, 22:97-101.
48. Rodacki M., Svoren B., Butty V., Besse W., Laffel L., Benoist C., Mathis D. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007, 56:177-185.